0001104659-21-033323.txt : 20210308 0001104659-21-033323.hdr.sgml : 20210308 20210308164228 ACCESSION NUMBER: 0001104659-21-033323 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210305 FILED AS OF DATE: 20210308 DATE AS OF CHANGE: 20210308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MOORHEAD DANIEL J CENTRAL INDEX KEY: 0001536000 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38804 FILM NUMBER: 21722508 MAIL ADDRESS: STREET 1: 9777 PYRAMID CT STREET 2: STE 100 CITY: ENGLEWOOD STATE: CO ZIP: 80112 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ZYNEX INC CENTRAL INDEX KEY: 0000846475 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 870403828 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9555 MAROON CIRCLE CITY: ENGLEWOOD STATE: CO ZIP: 80112 BUSINESS PHONE: (303) 867-3904 MAIL ADDRESS: STREET 1: 9555 MAROON CIRCLE CITY: ENGLEWOOD STATE: CO ZIP: 80112 FORMER COMPANY: FORMER CONFORMED NAME: ZYNEX MEDICAL HOLDINGS INC DATE OF NAME CHANGE: 20050812 FORMER COMPANY: FORMER CONFORMED NAME: ZYNEX MEDICAL HOLDINGS INC DATE OF NAME CHANGE: 20040120 FORMER COMPANY: FORMER CONFORMED NAME: FOX RIVER HOLDINGS INC DATE OF NAME CHANGE: 20031126 4 1 tm219055d1_form4.xml FORM 4 X0306 4 2021-03-05 0 0000846475 ZYNEX INC ZYXI 0001536000 MOORHEAD DANIEL J C/O ZYNEX, INC. 9555 MAROON CIRCLE ENGLEWOOD CO 80112 0 1 0 0 Chief Financial Officer Common Stock (Restricted Stock Award) 2021-03-05 4 A 0 5000 0 A 99949 D Common Stock 2021-03-05 4 F 0 1359 14.75 D 31374 D Represents a restricted stock award issued pursuant to the Issuer's 2017 Stock Incentive Plan (the "Plan") pursuant to which the 5,000 shares vest equally, on an annual basis, over a period of four years beginning one year from the grant date. Represents restricted stock awards under the Plan, which have not vested. Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of Restricted Stock Awards ("RSAs") and does not represent a sale. /s/ Daniel Moorhead 2021-03-08